Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)

Tadahiro Shoji; Eriko Takatori; Hideo Omi; Seisuke Kumagai; Akira Yoshizaki; Yoshihito Yokoyama; Hideki Mizunuma; Toshio Fujimoto; Tadao Takano; Nobuo Yaegashi; Toru Tase; Kenji Nakahara; Hirohisa Kurachi; Hiroshi Nishiyama; Toru Sugiyama

doi:10.1097/IGC.0b013e3181ffbe9f

Article info

Ovarian Cancer

Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)

Authors

Tadahiro Shoji Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Morioka; PubMed articles Google scholar articles
Eriko Takatori Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Morioka; PubMed articles Google scholar articles
Hideo Omi Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Morioka; PubMed articles Google scholar articles
Seisuke Kumagai Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Morioka; PubMed articles Google scholar articles
Akira Yoshizaki Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Morioka; PubMed articles Google scholar articles
Yoshihito Yokoyama Department of Obstetrics and Gynecology, Hirosaki University School of Medicine, Hirosaki; PubMed articles Google scholar articles
Hideki Mizunuma Department of Obstetrics and Gynecology, Hirosaki University School of Medicine, Hirosaki; PubMed articles Google scholar articles
Toshio Fujimoto Department of Obstetrics and Gynecology, Akita University School of Medicine, Akita; PubMed articles Google scholar articles
Tadao Takano Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai; PubMed articles Google scholar articles
Nobuo Yaegashi Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai; PubMed articles Google scholar articles
Toru Tase Department of Gynecology, Miyagi Cancer Center, Natori; PubMed articles Google scholar articles
Kenji Nakahara Department of Obstetrics and Gynecology, Yamagata University School of Medicine; Yamagata; and PubMed articles Google scholar articles
Hirohisa Kurachi Department of Obstetrics and Gynecology, Yamagata University School of Medicine; Yamagata; and PubMed articles Google scholar articles
Hiroshi Nishiyama Department of Obstetrics and Gynecology, Fukushima Medical University School of Medicine, Fukushima, Japan. PubMed articles Google scholar articles
Toru Sugiyama Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Morioka; PubMed articles Google scholar articles

Address correspondence and reprint requests to Tadahiro Shoji, MD, PhD, Uchimaru 19-1, Morioka. E-mail: tshoji{at}iwate-med.ac.jp.

Citation

Shoji T, Takatori E, Omi H, et al

Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)

International Journal of Gynecologic Cancer 2011;21:44-50.

Publication history

Received July 23, 2010
First published January 1, 2011.

Online issue publication

June 17, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password